KRAS and familial pancreatic carcinoma: Even though our study does not point to an essential function for KSR1 in KRAS-driven pancreatic cancer with heterozygous loss of p53, we cannot rule out a supporting role for KSR1, or a function in other contexts, and further work will be needed to dissect the complexities of KSR signaling.